Compositional changes of b and t cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study

HIGHLIGHTS

• who: Nele Claes and collaborators from the Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium, Rehabilitation and MS-Center, Neurology, Orbis Medical Center, Sittard, The Netherlands have published the paper: Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study, in the Journal: PLOS ONE | www.plosone.org of October/31,/2014
• what: Limitations of the study are the lack of functional data, although the authors provide evidence that during fingolimod treatment expression of functionally relevant markers . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.